Table 3 Diseases and exposure-response relationships included in this assessment

PM_2.5

Asthma

W113

1.009

f(RR, E)^c

Pope et al. 2002 [33]

PAF(E, RR) × BoD₂₀₀₄

Lung cancer

W067

1.014

f(RR, E)^c

Pope et al. 2002 [33]

PAF(E, RR) × BoD₂₀₀₄

CV-diseases

W104

1.009

f(RR, E)^c

Pope et al. 2002 [33]

PAF(E, RR) × BoD₂₀₀₄

COPD

W112

1.009

f(RR, E)^c

Pope et al. 2002 [33]

PAF(E, RR) × BoD₂₀₀₄

Outdoor bioaerosols

Asthma

W113

n/a

0.1^d

Jantunen et al., 2010 [22]

PAF × BoD₂₀₀₄

VOC

Asthma

W113

n/a

0.05^e

Jantunen et al., 2010 [22]

C/C_EU × PAF × BoD₂₀₀₄

CO

Acute toxication caused by carbon monoxide

n/a

n/a

0.9^e

Jantunen et al., 2010 [22]

Cases x 20 years lost/case

Radon

Lung cancer

W067

1.0014

f(RR, E)^c

Darby et al., 2005 [34]

PAF(E, RR) × BoD₂₀₀₄

Home dampness

Respiratory infections

W038

1.37

f(RR, E)^c

Fisk et al., 2007 [35]

PAF(E, RR) × BoD₂₀₀₄

Asthma

W113

1.5

f(RR, E)^c

Fisk et al., 2007 [35]

PAF(E, RR) × BoD₂₀₀₄

SHS^f

Lung cancer

W067

1.21

f(RR, E)^c

US S.G. 2006 [36]

PAF(E, RR) × BoD₂₀₀₄

Ischaemic heart disease

W107

1.27

f(RR, E)^c

US S.G. 2006 [36]

PAF(E, RR) × BoD₂₀₀₄

Asthma

W113

1.97

f(RR, E)^c

Jaakkola et al., 2003 [37]

PAF(E, RR) × BoD₂₀₀₄